---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-032264"
form_type: "8-K"
ticker: "MTNB"
cik: "0001582554"
company_name: "Matinas BioPharma Holdings, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:13:02.139277+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Matinas BioPharma annual meeting results: directors elected, say-on-pay approved, auditor ratified

## Summary
- All 7 director nominees elected with ~92% of votes cast for each; broker non-votes ~62.5M shares.
- Advisory vote on executive compensation passed with 56.5M for, 6.9M against, 1.1M abstain.
- Ratification of EisnerAmper as auditor for FY 2022 approved with 126.1M for, 0.5M against, 0.5M abstain.

## SEC filing metadata
- accession: 0001493152-22-032264
- form_type: 8-K
- ticker: MTNB
- cik: 0001582554
- company_name: Matinas BioPharma Holdings, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/0001493152-22-032264-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-032264
- JSON: https://secwatch.observer/filing/0001493152-22-032264.json
- Plain text: https://secwatch.observer/filing/0001493152-22-032264.txt

## Key facts
- Shareholder Votes
  Matinas BioPharma Holdings, Inc. shareholders approved Advisory vote on compensation of the Company's named executive officers at the 2022-11-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2022-11-14
  source text: The tabulation of votes with respect to this proposal was as follows: For Against Abstain Broker Non-Votes 56,522,115 6,902,448 1,110,330 62,538,516
  evidence_url: https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/0001493152-22-032264-index.htm
- Shareholder Votes
  Matinas BioPharma Holdings, Inc. shareholders approved Ratification of appointment of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending December 31, 2022 at the 2022-11-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2022-11-14
  source text: The tabulation of votes with respect to this proposal was as follows: For Against Abstain Broker Non-Votes 126,116,312 468,604 488,493 - -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/0001493152-22-032264-index.htm
- Shareholder Votes
  Matinas BioPharma Holdings, Inc. shareholders approved Election of directors to serve on the board of directors until the annual meeting of shareholders to be held in 2023 at the 2022-11-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2022-11-14
  source text: The tabulation of votes with respect to the election of such directors was as follows: AUTHORITY BROKER FOR WITHELD NON-VOTE Herbert Conrad 59,278,388 5,256,505 62,538,516 Kathryn Corzo 59,698,087 4,836,806 62,538,516 Jerome D. Jabbour 60,041,871 4,493,022 62,538,516 Eric Ende 59,832,977 4,701,916 62,538,516 Natasha Giordano 59,185,407 5,349,486 62,538,516 James Scibetta 60,052,024 4,482,869 62,538,516 Matthew Wikler 60,446,318 4,088,575 62,538,516
  evidence_url: https://www.sec.gov/Archives/edgar/data/1582554/000149315222032264/0001493152-22-032264-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.